Abstract:Background Previous reports suggest septal hypertrophy with an interventricular septum depth (IVSD) ≥ 14 mm may adversely affect outcomes after transcatheter aortic valve implantation (TAVI) due to suboptimal valve placement, valve migration, or residual increased LVOT pressure gradients. Aims This analysis investigates the impact of interventricular septal hypertrophy on acute outcomes after TAVI. Methods Between 2009 and 2021, 1033 consecutive patients (55.8% male, 80.5 ± 6.7 years, EuroSCORE II 6.3 ± 6.5%) with documented IVSD underwent TAVI at our center and were included for analysis. Baseline, periprocedural, and 30-day outcome parameters of patients with normal IVSD (< 14 mm; group 1) and increased IVSD (≥ 14 mm; group 2) were compared. Data were retrospectively analyzed according to updated Valve Academic Research Consortium-3 (VARC-3) definitions. Comparison of outcome parameters was adjusted for baseline differences between groups using logistic and linear regression analyses. Results Of 1033 patients, 585 and 448 patients were allocated to groups 1 and 2, respectively. There was no significant difference between groups regarding transfemoral access rate (82.6% ( n = 478) vs. 86.0% ( n = 381), p = 0.157). Postprocedural mean transvalvular pressure gradient was significantly increased in group 2 (group 1, 7.8 ± 4.1 mmHg, vs. group 2, 8.9 ± 4.9 mmHg, p = 0.046). Despite this finding, there was no significant difference between groups regarding the rates of VARC-3 adjudicated composite endpoint device success (90.0% ( n = 522) vs. 87.6% ( n = 388), p = 0.538) or technical success (92.6% ( n = 542) vs. 92.6% ( n = 415), p = 0.639). Moreover, the groups showed no significant differences regarding the rates of paravalvular leakage ≥ moderate (3.1% ( n = 14) vs. 2.6% ( n = 9), p = 0.993), postprocedural permanent pacemaker implantation (13.4% ( n = 77) vs. 13.8% ( n = 61), p = 0.778), or 30-day mortality (5.1% ( n = 30) vs. 4.5% ( n = 20), p = 0.758). Conclusion Although transvalvular mean pressure gradients were significantly higher in patients with increased IVSD after TAVI, acute outcomes were comparable between groups suggesting no early impact of adverse hemodynamics due to elevated IVSD. However, how these differences in hemodynamic findings may affect mid- and long-term outcomes, especially in terms of valve durability, needs to be evaluated in further investigations. Graphical

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the acute - phase effects of transcatheter aortic valve implantation (TAVI) in patients with significant interventricular septal thickening (IVSD ≥ 14 mm). Specifically, the study aims to explore the impact of interventricular septal thickening on the immediate results after TAVI, including valve function, complication incidence, and clinical outcomes within 30 days. ### Research Background - **Background**: Previous studies have shown that an interventricular septal depth (IVSD) ≥ 14 mm may adversely affect the results of TAVI due to suboptimal valve placement, valve displacement, or an increased left ventricular outflow tract (LVOT) pressure gradient. - **Objective**: This analysis aims to study the impact of interventricular septal thickening on the acute - phase results after TAVI. ### Research Methods - **Research Subjects**: A total of 1,033 consecutive patients who underwent TAVI at the research center between 2009 and 2021 and had IVSD records were included in the analysis. - **Grouping**: According to IVSD, they were divided into two groups: - Group 1: Normal IVSD (< 14 mm) - Group 2: Increased IVSD (≥ 14 mm) - **Data Collection and Statistical Analysis**: Baseline, peri - operative, and 30 - day outcome parameters were compared, and baseline differences were adjusted using logistic regression and linear regression analysis. ### Main Findings - **Baseline Characteristics**: There were significant differences between the two groups of patients in terms of gender, EuroSCORE II score, severely reduced ejection fraction (LVEF ≤ 30%), and the baseline mean aortic valve pressure gradient (Pmean). - **Post - operative Results**: - The mean postoperative transvalvular pressure gradient was significantly increased in Group 2 (Group 1: 7.8 ± 4.1 mmHg, Group 2: 8.9 ± 4.9 mmHg, p = 0.046). - Nevertheless, there were no significant differences between the two groups in terms of the VARC - 3 - adjudicated composite endpoint device success (90.0% vs. 87.6%, p = 0.538) and technical success (92.6% vs. 92.6%, p = 0.639). - There were also no significant differences between the two groups in terms of moderate or greater paravalvular leakage (3.1% vs. 2.6%, p = 0.993), postoperative permanent pacemaker implantation (13.4% vs. 13.8%, p = 0.778), and 30 - day mortality (5.1% vs. 4.5%, p = 0.758). ### Conclusions - **Main Conclusion**: Although the mean postoperative transvalvular pressure gradient was significantly increased in patients with increased IVSD, the acute - phase results were similar between the two groups, indicating that an increased IVSD did not lead to adverse hemodynamic effects in the early stage. However, how these hemodynamic differences affect the medium - and long - term results, especially valve durability, requires further research to evaluate. ### Practical Significance - **Impact on Daily Practice**: In the presence of interventricular septal thickening, TAVI is feasible in most patients, with high surgical safety and acute - phase efficacy. However, a heart team discussion is still necessary for patients with significant interventricular septal thickening.

Transcatheter aortic valve implantation in patients with significant septal hypertrophy

Impact of right and left ventricular systolic dysfunction on perioperative outcome and long-term survival after transcatheter aortic valve replacement

Transcatheter aortic valve implantation reduces grade of concomitant mitral and tricuspid valve regurgitation and pulmonary hypertension

Development of In-Hospital Outcomes in Patients undergoing Transcatheter Aortic Valve Implantation (TAVI) at an Interdisciplinary Heart Center: A Single-Center Experience of 489 Consecutive Cases

Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study

Extent of Cardiac Damage and Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients

Procedural Results of Patients Undergoing Transcatheter Aortic Valve Implantation With Aortic Annuli Diameter ≥26 mm: insights from the German Aortic Valve Registry

Absolute coronary flow and microvascular resistance before and after transcatheter aortic valve implantation

Asymmetrical Expansion of Balloon-Expandable Transcatheter Aortic Valve Prostheses: Implications for Valve Hemodynamic and Clinical Outcomes

Impact of Moderate to Severe Mitral and Tricuspid Valves Regurgitation after Transcatheter Aortic Valve Implantation: A Multicenter Retrospective Study

Impact of left ventricular end-diastolic pressure as a marker for diastolic dysfunction on long-term outcomes in patients undergoing transcatheter aortic valve replacement

Impact of Baseline Left Ventricular Ejection Fraction on Mid-term Outcomes in Women Undergoing Transcatheter Aortic Valve Implantation: Insight from the WIN TAVI Registry

Mitral-Tricuspid Regurgitation Change After Transcatheter Aortic Valve Implantation and Its Effect on Mortality and Hospitalization

Comprehensive Myocardial Assessment by Computed Tomography: Impact on Short-Term Outcomes After Transcatheter Aortic Valve Replacement

Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement

Natural History of Mitral Regurgitation After Transcatheter Aortic Valve Implantation

The Impact of Severe Ventricular Remodeling on Quality-of-Life Outcomes after Transcatheter Aortic Valve Replacement

Improved Hemodynamics with Self-Expanding Compared to Balloon Expandable Transcatheter Aortic Valve Implantation in Small Annulus Patients: A Propensity-Matched Analysis

Transcatheter aortic valve implantation and its impact on endothelial function in patients with aortic stenosis

Incidence, Predictors, and Outcomes of Paravalvular Regurgitation after TAVR in Sievers Type-1 Bicuspid Aortic Valves